07/21/2021
7:00 AM | Teva Pharmaceutical Industries (Filer)
Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2021
7:23 AM | Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2021
7:22 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2021
7:21 AM | Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2021
7:20 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2021
7:20 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2021
7:19 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2021
7:18 AM | Hussain Abbas (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2021
7:15 AM | Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2021
7:13 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/16/2021
7:12 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2021
7:10 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2021
7:12 AM | Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2021
6:47 AM | Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2021
6:46 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2021
6:45 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2021
6:43 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2021
6:42 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2021
6:41 AM | Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2021
6:40 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2021
6:39 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2021
6:39 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2021
7:19 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2021
6:32 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2021
6:30 AM | Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2021
6:30 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2021
6:29 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2021
6:27 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2021
6:26 AM | Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2021
6:25 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2021
6:23 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2021
7:41 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2021
6:48 AM | Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2021
6:46 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2021
6:45 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2021
6:44 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2021
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2021
3:13 PM | Teva Pharmaceutical Industries (Filer)
| Form DEFA14A
| |
04/21/2021
3:11 PM | Teva Pharmaceutical Industries (Filer)
| Form DEF 14A
| |
02/17/2021
3:11 PM | Teva Pharmaceutical Industries (Issuer)
Weil Andrew (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/17/2021
3:09 PM | Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
3:08 PM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
3:07 PM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2021
2:58 PM | Capital Research Global Investors (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SC 13G/A
| |
02/11/2021
3:12 PM | Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2021
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2021
12:13 PM | Teva Pharmaceutical Industries (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
01/25/2021
3:02 PM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2020
3:09 PM | Teva Pharmaceutical Industries (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2020
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2020
6:42 AM | Schultz Kare (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2020
8:04 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2020
3:11 PM | Hussain Abbas (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2020
3:09 PM | Hussain Abbas (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/17/2020
11:15 PM | Teva Pharmaceutical Finance Netherlands II B.V. (Filer)
Teva Pharmaceutical Finance Netherlands III B.V. (Filer)
Teva Pharmaceutical Industries (Filer)
| Form EFFECT
| |
08/17/2020
8:12 AM | Teva Pharmaceutical Finance Netherlands II B.V. (Filer)
Teva Pharmaceutical Finance Netherlands III B.V. (Filer)
Teva Pharmaceutical Industries (Filer)
| Form 424B3
| |
08/14/2020
10:17 AM | Teva Pharmaceutical Industries (Filer)
| Form SD
Specialized Disclosure Report | |
08/13/2020
3:15 PM | Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2020
3:14 PM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2020
3:13 PM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2020
3:12 PM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2020
3:09 PM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2020
3:07 PM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2020
3:06 PM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2020
3:16 PM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2020
3:47 PM | Teva Pharmaceutical Finance Netherlands II B.V. (Filer)
Teva Pharmaceutical Finance Netherlands III B.V. (Filer)
Teva Pharmaceutical Industries (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
08/05/2020
3:43 PM | Teva Pharmaceutical Industries (Filer)
| Form S-8 POS
| |
08/05/2020
3:42 PM | Teva Pharmaceutical Industries (Filer)
| Form S-8 POS
| |
08/05/2020
3:42 PM | Teva Pharmaceutical Industries (Filer)
| Form S-8 POS
| |
08/05/2020
6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2020
6:37 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:36 AM | Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:35 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:35 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:34 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:33 AM | Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:32 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:31 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:31 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:18 AM | Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:17 AM | Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/11/2020
6:16 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:15 AM | Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:14 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:13 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:13 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:12 AM | Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:11 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:10 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
6:09 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2020
7:28 AM | Teva Pharmaceutical Industries (Filer)
| Form DEFA14A
| |
05/07/2020
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2020
6:57 AM | Teva Pharmaceutical Industries (Filer)
| Form DEFA14A
| |
04/22/2020
6:54 AM | Teva Pharmaceutical Industries (Filer)
| Form DEF 14A
| |
03/19/2020
3:19 PM | Teva Pharmaceutical Industries (Filer)
| Form PRE 14A
| |
03/19/2020
7:09 AM | Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2020
6:38 AM | Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2020
6:37 AM | O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2020
6:36 AM | Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2020
6:33 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
